Journal of Medical Economics
Volume 24, 2021 - Issue 1
Renal Disease
Healthcare utilization and expenditures associated with hyperkalemia management: a retrospective study of Medicare Advantage patients
Nihar R. Desaia Center for Outcomes Research and Evaluation, Yale University, New Haven, CT, USACorrespondence[email protected]
https://orcid.org/0000-0003-2384-2545
https://orcid.org/0000-0003-2384-2545, Paula J. Alvarezb Vifor Pharma, Inc., Redwood City, CA, USAhttps://orcid.org/0000-0003-2865-5124
https://orcid.org/0000-0003-2865-5124, Ladan Golestanehc Renal Division, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USAhttps://orcid.org/0000-0003-1848-582X
https://orcid.org/0000-0003-1848-582X, Steven D. Woodsb Vifor Pharma, Inc., Redwood City, CA, USAhttps://orcid.org/0000-0001-9271-370X
https://orcid.org/0000-0001-9271-370X, Steven G. Cocad Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USAhttps://orcid.org/0000-0002-0928-9168
https://orcid.org/0000-0002-0928-9168 & Christopher G. Rowane COHRDATA, San Clemente, CA, USAhttps://orcid.org/0000-0002-4318-2970
https://orcid.org/0000-0002-4318-2970